Latest filing published 16 Dec 2011 for COMPLETE GENOMICS INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew E. Senyei: trading record in brief
This profile gathers the share dealings of Andrew E. Senyei across 2 companies, led by Complete Genomics Inc and Genoptix Inc. Between 2 November 2007 and 14 December 2011, the trades on record add up to 50 filings.
Both buying and selling appear: 2 purchases worth €971k, against 3 sales worth €16.1M. On balance, insiders were net sellers of €15.1M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 20 share grants and 1 option exercise. 2011 to date brings 1 purchase and no sales.
On 16 December 2011 came the latest disclosure, an option exercise in Complete Genomics Inc. The most recent open-market purchase was published on 16 December 2011, 5,441 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew E. Senyei
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,666 shares0Common Stock, par value $0.001SEC:0001181431-11-060888:0
- 100,000 shares@ US$3.05Common Stock, par value $0.001SEC:0001181431-11-060888:1Canonical exit: 13 Mar 2012 (T+90)
- 16,917 shares@ US$25.00Common StockSEC:0001181431-11-014287:0
- 79 shares@ US$25.00Common StockSEC:0001181431-11-014287:1
- 6,700 shares@ US$25.00Common StockSEC:0001181431-11-014287:2
- 500 shares@ US$16.93Common StockSEC:0001181431-10-059316:0
- 66,138 sharesCommon Stock, par value $0.001SEC:0001181431-10-055847:0
- 27,049 sharesCommon Stock, par value $0.001SEC:0001181431-10-055847:1
- 176,737 sharesCommon Stock, par value $0.001SEC:0001181431-10-055847:2
- 259,458 sharesCommon Stock, par value $0.001SEC:0001181431-10-055847:3
- 138,794 shares@ US$7.56Common Stock, par value $0.001SEC:0001181431-10-055847:4
- 23,133 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055847:5
- 17,261 shares@ US$7.56Common Stock, par value $0.001SEC:0001181431-10-055847:6
- 14,500 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055847:7
- 8,378 shares@ US$7.56Common Stock, par value $0.001SEC:0001181431-10-055847:8
- 7,038 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055847:9
- 111,111 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055847:10Canonical exit: 14 Feb 2011 (T+90)
- 315,746 sharesCommon Stock, par value $0.001SEC:0001181431-10-055846:0
- 257,677 sharesCommon Stock, par value $0.001SEC:0001181431-10-055846:1
- 177,084 sharesCommon Stock, par value $0.001SEC:0001181431-10-055846:2
- 488,789 sharesCommon Stock, par value $0.001SEC:0001181431-10-055846:3
- 547,094 sharesCommon Stock, par value $0.001SEC:0001181431-10-055846:4
- 308,930 shares@ US$1.50Common Stock, par value $0.001SEC:0001181431-10-055846:5
- 51,489 shares@ US$9.00Common Stock, par value $0.001SEC:0001181431-10-055846:6
- 32,364 shares@ US$7.56Common Stock, par value $0.001SEC:0001181431-10-055846:7
25 of 45 declarations
